Clinical Characterization of Respiratory Syncytial Virus Infection in Adults: A Neglected Disease?
influenza A virus
influenza B virus
respiratory syncytial virus
severe acute respiratory syndrome
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
31 08 2023
31 08 2023
Historique:
received:
14
07
2023
revised:
14
08
2023
accepted:
23
08
2023
medline:
29
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
Lower respiratory tract infections (LRIs) are a significant cause of disability-adjusted life-years (DALYs) across all age groups, especially in children under 9 years of age, and adults over 75. The main causative agents are viruses, such as influenza and respiratory syncytial virus (RSV). Viral LRIs in adults have historically received less attention. This study investigated the incidence of RSV and influenza in adult patients admitted to a referral hospital, as well as the clinical profile of these infections. Molecular testing was conducted on nasopharyngeal samples taken from a respiratory surveillance cohort comprising adult (15-59 years) and elderly (60+ years) hospitalized patients who tested negative for SARS-CoV-2, to determine the prevalence for influenza and RSV. Influenza was found to be less frequent among the elderly. The main symptoms of RSV infections were cough, fever, dyspnea, malaise, and respiratory distress, while headache, nasal congestion, a sore throat, and myalgia were most frequent in influenza. Elderly patients with RSV were not found to have more severe illness than adults under age 60, underscoring the importance of providing the same care to adults with this viral infection.
Identifiants
pubmed: 37766255
pii: v15091848
doi: 10.3390/v15091848
pmc: PMC10536488
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : U01 AI151807
Pays : United States
Références
Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 2):S4-12
pubmed: 7551411
Influenza Other Respir Viruses. 2022 Jan;16(1):151-158
pubmed: 34605182
J Infect Dis. 2022 Aug 15;226(Suppl 2):S225-S235
pubmed: 35968875
Lancet. 2022 Aug 27;400(10353):693-706
pubmed: 36030813
Lancet. 2011 Dec 3;378(9807):1917-30
pubmed: 22078723
Lancet Respir Med. 2021 Sep;9(9):1030-1049
pubmed: 34411511
J Clin Virol. 2019 Aug;117:103-108
pubmed: 31280089
Clin Infect Dis. 2011 May;52 Suppl 4:S284-9
pubmed: 21460286
Pediatr Ann. 2018 Sep 1;47(9):e371-e376
pubmed: 30208197
N Engl J Med. 2005 Apr 28;352(17):1749-59
pubmed: 15858184
Vaccines (Basel). 2022 May 23;10(5):
pubmed: 35632577
Am J Epidemiol. 2007 Jun 15;165(12):1434-42
pubmed: 17369609
J Med Virol. 2021 Aug;93(8):4638-4646
pubmed: 33792930
Eur Respir Rev. 2022 Oct 19;31(166):
pubmed: 36261158
Nat Commun. 2022 May 24;13(1):2884
pubmed: 35610217
J Infect Dev Ctries. 2022 Oct 31;16(10):1614-1622
pubmed: 36332215
Lancet. 2017 Sep 2;390(10098):946-958
pubmed: 28689664
Lancet. 2001 Oct 27;358(9291):1382-3
pubmed: 11705477
J Infect Dis. 2020 Aug 17;222(6):962-966
pubmed: 32300806